| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.51 | 0.09 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.4 | 0.3 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.29 | 0.09 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.28 | 0.05 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.26 | 0.09 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.16 | 0.2 |